Skip to main content

Doxycycline Oral Suspension

Last Updated: September 12, 2022
Status: Current

Products Affected - Description
    • Vibramycin Calcium oral suspension, Pfizer, 50 mg/5 mL, 473 mL bottle, NDC 00069-0971-95
    • Vibramycin Monohydrate oral powder for suspension, Pfizer, 25 mg/5 mL, 60 mL bottle, NDC 00069-0970-65 - discontinued
    • Doxycycline monohydrate oral powder for suspension, Cipla USA, 25 mg/5 mL, 60 mL bottle, NDC 69097-0228-43 - discontinued
Reason for the Shortage
    • Cipla discontinued doxycycline monohydrate powder for oral suspension in 2021.
    • Pfizer has Vibramycin Calcium oral suspension on shortage due to manufacturing delay.
    • Pfizer discontinued Vibramycin Monohydrate powder for oral suspension in November 2021.
    • Lupin has doxycycline monohydrate powder for oral suspension available.
Available Products
    • Doxycycline monohydrate oral powder for suspension, Lupin, 25 mg/5 mL, 60 mL bottle, NDC 68180-0657-01

Estimated Resupply Dates

    • Pfizer has Vibramycin calcium oral suspension 50 mg/5 mL in 473 mL bottles on back order and the company cannot estimate a release date.

Updated

Updated September 12, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 16, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.